Skip to main content
Clinical Trials/NCT03876509
NCT03876509
Completed
Not Applicable

Non-invasive Diagnosis of Pulmonary Hypertension by Thoracic Impedance Cardiography - a Prospective Study

Medical University of Graz1 site in 1 country86 target enrollmentJuly 4, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pulmonary Hypertension
Sponsor
Medical University of Graz
Enrollment
86
Locations
1
Primary Endpoint
Diagnosis of pulmonary hypertension
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The goal of the study is to prospectively evaluate Impedance Cardiography as a tool to detect pulmonary hypertension. According to our hypothesis Impedance Cardiography is a valuable method to differentiate patients without pulmonary hypertension from patients with pulmonary hypertension. The main objective is to determine the sensitivity and specificity in comparison to the gold standard right heart catheterization.

Registry
clinicaltrials.gov
Start Date
July 4, 2018
End Date
June 30, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Medical University of Graz
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Written Informed Consent
  • Patients with clinical indication for right heart catheterization

Exclusion Criteria

  • known Pregnancy

Outcomes

Primary Outcomes

Diagnosis of pulmonary hypertension

Time Frame: 1 hour

The sensitivity and specificity of Impedance Cardiography in the diagnosis of pulmonary Hypertension (as compared with the Gold Standard right heart catheterization) will be determined.

Study Sites (1)

Loading locations...

Similar Trials